BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
|Open|| Short (1M)
Motilal Oswal Recommends 'Buy' On Ipca Laboratories
According to Motilal Oswal, Ipca Laboratories is one of the companies with high exposure to domestic formulation, a favorable opportunity in API and better traction in international generics. The acquisition of Nobel Explochem will help Ipca Laboratories in backward integration and in improving margins in the long term, the brokerage adds.